Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ozmosis Research specializes in the design and management of Phase I–III clinical trials with deep expertise in oncology. The company operates as a social enterprise CRO spun out from Princess Margaret Cancer Centre. It partners with pharmaceutical/biotech companies and academic investigators to expedite trial initiation and patient recruitment across North America, Europe, and Australia. Its leadership includes recognized experts from leading Canadian research institutions. The company does not have its own drug pipeline but has an extensive track record supporting complex cancer studies including those involving novel molecular targeted therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ozmosis Research.